+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Cannabidiol"

From
From
From
From
From
Insomnia - Market Insight, Epidemiology And Market Forecast - 2032 - Product Thumbnail Image

Insomnia - Market Insight, Epidemiology And Market Forecast - 2032

  • Report
  • February 2023
  • 198 Pages
  • Global
From
From
Medical Marijuana - Cannabidiol - Pipeline Insight, 2025 - Product Thumbnail Image

Medical Marijuana - Cannabidiol - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 80 Pages
  • Global
From
Cannabidiol (CBD) Pain - Pipeline Insight, 2025 - Product Thumbnail Image

Cannabidiol (CBD) Pain - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Dravet Syndrome- Pipeline Insight, 2025 - Product Thumbnail Image

Dravet Syndrome- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Cannabinoid Receptor CB1 Inverse Agonists - Pipeline Insight, 2025 - Product Thumbnail Image

Cannabinoid Receptor CB1 Inverse Agonists - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Corticobasal Degeneration (CBD) - Pipeline Insight, 2025 - Product Thumbnail Image

Corticobasal Degeneration (CBD) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Cannabinoid Agonist - Pipeline Insight, 2025 - Product Thumbnail Image

Cannabinoid Agonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Systemic Sclerosis - Pipeline Insight, 2025 - Product Thumbnail Image

Systemic Sclerosis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Fragile X Syndrome - Pipeline Insight, 2025 - Product Thumbnail Image

Fragile X Syndrome - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Dup15q Syndrome - Pipeline Insight, 2025 - Product Thumbnail Image

Dup15q Syndrome - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Sturge-Weber Syndrome - Pipeline Insight, 2025 - Product Thumbnail Image

Sturge-Weber Syndrome - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Tuberous Sclerosis- Pipeline Insight, 2025 - Product Thumbnail Image

Tuberous Sclerosis- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Doose Syndrome - Pipeline Insight, 2025 - Product Thumbnail Image

Doose Syndrome - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
Loading Indicator

Cannabidiol (CBD) is a cannabinoid found in the Cannabis sativa plant. It is a non-psychoactive compound that has been studied for its potential therapeutic effects on the central nervous system (CNS). CBD has been found to have anti-inflammatory, antioxidant, and neuroprotective properties, and has been studied for its potential to treat a variety of neurological disorders, including epilepsy, anxiety, depression, and Parkinson's disease. CBD is increasingly being used as an alternative to traditional CNS drugs, such as benzodiazepines and opioids. It is being studied for its potential to reduce the side effects of traditional medications, as well as its potential to treat a variety of neurological conditions. The CBD market is growing rapidly, with a variety of products available, including oils, tinctures, edibles, and topical creams. Companies in the market include Charlotte's Web, Elixinol, and Endoca. Show Less Read more